Back to
VIKING GLOBAL INVESTORS LP
ARTV1 quarters
Position history for
VIKING GLOBAL INVESTORS LP's holdings in ARTIVA BIOTHERAPEUTICS INC
Yes. Viking Global Investors holds 2,604,166 shares of ARTV (Artiva Biotherapeutics), worth $25.3M, as of its Q2 2026 13F filing. It opened the position in Q2 2026. ARTV is 0.1% of Viking Global Investors' reported 13F portfolio.
Current Value
$25.3M
Current Shares
2.6M
Total Value Change
$0
Total Shares Change
0
Quarter-by-Quarter History
Other major holders of ARTV: RA CAPITAL MANAGEMENT, L.P.